-
1
-
-
59849120163
-
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow-up
-
Marcucci R, Gori AM, Paniccia R et al (2009) Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation 119:237-242
-
(2009)
Circulation
, vol.119
, pp. 237-242
-
-
Marcucci, R.1
Gori, A.M.2
Paniccia, R.3
-
2
-
-
80052167250
-
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: A collaborative meta-analysis of individual participant data
-
Brar SS, ten Berg J, Marcucci M et al (2011) Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: a collaborative meta-analysis of individual participant data. J Am Coll Cardiol 58:1945-1954
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 1945-1954
-
-
Brar, S.S.1
Ten Berg, J.2
Marcucci, M.3
-
3
-
-
34047096264
-
Variability in Individual Responsiveness to Clopidogrel. Clinical Implications, Management, and Future Perspectives
-
DOI 10.1016/j.jacc.2006.11.044, PII S0735109707003385
-
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E et al (2007) Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 49:1505-1516 (Pubitemid 46517957)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.14
, pp. 1505-1516
-
-
Angiolillo, D.J.1
Fernandez-Ortiz, A.2
Bernardo, E.3
Alfonso, F.4
Macaya, C.5
Bass, T.A.6
Costa, M.A.7
-
4
-
-
84865694063
-
Antiplatelet therapy following myocardial infarction in patients with diabetes
-
Bhatt DL (2012) Antiplatelet therapy following myocardial infarction in patients with diabetes. JAMA 308:921-922
-
(2012)
JAMA
, vol.308
, pp. 921-922
-
-
Bhatt, D.L.1
-
6
-
-
23644433510
-
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
-
DOI 10.2337/diabetes.54.8.2430
-
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E et al (2005) Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54:2430-2435 (Pubitemid 41134272)
-
(2005)
Diabetes
, vol.54
, Issue.8
, pp. 2430-2435
-
-
Angiolillo, D.J.1
Fernandez-Ortiz, A.2
Bernardo, E.3
Ramirez, C.4
Sabate, M.5
Jimenez-Quevedo, P.6
Hernandez, R.7
Moreno, R.8
Escaned, J.9
Alfonso, F.10
Banuelos, C.11
Costa, M.A.12
Bass, T.A.13
Macaya, C.14
-
7
-
-
33745815689
-
Insulin Therapy Is Associated With Platelet Dysfunction in Patients With Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment
-
DOI 10.1016/j.jacc.2006.03.038, PII S0735109706010576
-
Angiolillo DJ, Bernardo E, Ramirez C et al (2006) Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol 48:298-304 (Pubitemid 44026661)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.2
, pp. 298-304
-
-
Angiolillo, D.J.1
Bernardo, E.2
Ramirez, C.3
Costa, M.A.4
Sabate, M.5
Jimenez-Quevedo, P.6
Hernandez, R.7
Moreno, R.8
Escaned, J.9
Alfonso, F.10
Banuelos, C.11
Bass, T.A.12
Macaya, C.13
Fernandez-Ortiz, A.14
-
8
-
-
33644870179
-
Platelet inhibition by insulin is absent in type 2 diabetes mellitus
-
DOI 10.1161/01.ATV.0000199519.37089.a0, PII 0004360520060200000034
-
Ferreira IA, Mocking AI, Feijge MA et al (2006) Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 26:417-422 (Pubitemid 43732209)
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.2
, pp. 417-422
-
-
Ferreira, I.A.1
Mocking, A.I.M.2
Feijge, M.A.H.3
Gorter, G.4
Van Haeften, T.W.5
Heemskerk, J.W.M.6
Akkerman, J.-W.N.7
-
9
-
-
79952168736
-
Diabetes and antiplatelet therapy in acute coronary syndrome
-
Jl Ferreiro, Angiolillo DJ (2011) Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation 123:798-813
-
(2011)
Circulation
, vol.123
, pp. 798-813
-
-
Ferreiro, Jl.1
Angiolillo, D.J.2
-
10
-
-
84869162101
-
Cardiovascular disease and diabetes: The vulnerable patients
-
Hess K, Marx N, Lehrke M (2012) Cardiovascular disease and diabetes: the vulnerable patients. Eur Heart J 14(suppl B):B4-B13
-
(2012)
Eur Heart J
, vol.14
, Issue.SUPPL. B
-
-
Hess, K.1
Marx, N.2
Lehrke, M.3
-
11
-
-
84865701469
-
Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes
-
Andersson C, Lyngbæk S, Nguyen CD et al (2012) Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. JAMA 308:882-889
-
(2012)
JAMA
, vol.308
, pp. 882-889
-
-
Andersson, C.1
Lyngbæk, S.2
Nguyen, C.D.3
-
12
-
-
33847130538
-
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: Results of the optimizing antiplatelet therapy in diabetes mellitus (OPTIMUS) study
-
DOI 10.1161/CIRCULATIONAHA.106.667741, PII 0000301720070213000008
-
Angiolillo DJ, Shoemaker SB, Desai B et al (2007) Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. Circulation 115:708-716 (Pubitemid 46294761)
-
(2007)
Circulation
, vol.115
, Issue.6
, pp. 708-716
-
-
Angiolillo, D.J.1
Shoemaker, S.B.2
Desai, B.3
Yuan, H.4
Charlton, R.K.5
Bernardo, E.6
Zenni, M.M.7
Guzman, L.A.8
Bass, T.A.9
Costa, M.A.10
-
13
-
-
52449085759
-
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Results of the OPTIMUS-2 study
-
Angiolillo DJ, Capranzano P, Goto S et al (2008) A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study. Eur Heart J 29:2202-2211
-
(2008)
Eur Heart J
, vol.29
, pp. 2202-2211
-
-
Angiolillo, D.J.1
Capranzano, P.2
Goto, S.3
-
14
-
-
79952149001
-
A pharmacodynamic comparison of prasugrel vs. High-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: Results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial
-
Angiolillo DJ, Badimon JJ, Saucedo JF et al (2011) A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. Eur Heart J 32:838-846
-
(2011)
Eur Heart J
, vol.32
, pp. 838-846
-
-
Angiolillo, D.J.1
Badimon, J.J.2
Saucedo, J.F.3
-
15
-
-
79961056489
-
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy
-
Angiolillo DJ, Capranzano P, Ferreiro JL et al (2011) Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy. Thromb Haemost 106:253-262
-
(2011)
Thromb Haemost
, vol.106
, pp. 253-262
-
-
Angiolillo, D.J.1
Capranzano, P.2
Ferreiro, J.L.3
-
16
-
-
84871719026
-
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status
-
Capranzano P, Ferreiro JL, Ueno M et al (2013) Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status. Catheter Cardiovasc Interv 81:42-49
-
(2013)
Catheter Cardiovasc Interv
, vol.81
, pp. 42-49
-
-
Capranzano, P.1
Ferreiro, J.L.2
Ueno, M.3
-
17
-
-
55949103494
-
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38
-
TRITON-TIMI 38 Investigators
-
Wiviott SD, Braunwald E, Angiolillo DJ, TRITON-TIMI 38 Investigators et al (2008) Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation 118:1626-1636
-
(2008)
Circulation
, vol.118
, pp. 1626-1636
-
-
Wiviott, S.D.1
Braunwald, E.2
Angiolillo, D.J.3
-
18
-
-
78650368771
-
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: A substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
-
PLATO Study Group
-
James S, Angiolillo DJ, Cornel JH et al PLATO Study Group (2010) Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J 31:3006-3016
-
(2010)
Eur Heart J
, vol.31
, pp. 3006-3016
-
-
James, S.1
Angiolillo, D.J.2
Cornel, J.H.3
-
19
-
-
84860390388
-
Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel
-
Ueno M, Ferreiro JL, Tomasello SD et al (2011) Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. JACC Cardiovasc Interv 4:905-912
-
(2011)
JACC Cardiovasc Interv
, vol.4
, pp. 905-912
-
-
Ueno, M.1
Ferreiro, J.L.2
Tomasello, S.D.3
-
20
-
-
84870356894
-
Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus
-
Suryadevara S, Ueno M, Tello-Montoliu A et al (2012) Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus. Thromb Haemost 108:930-936
-
(2012)
Thromb Haemost
, vol.108
, pp. 930-936
-
-
Suryadevara, S.1
Ueno, M.2
Tello-Montoliu, A.3
-
21
-
-
79955155110
-
Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo
-
Vivas D, García-Rubira JC, Bernardo E et al (2011) Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo"). Heart 97:803-809
-
(2011)
Heart
, vol.97
, pp. 803-809
-
-
Vivas, D.1
García-Rubira, J.C.2
Bernardo, E.3
-
22
-
-
18444374227
-
Clinical significance of statin pleiotropic effects hypotheses versus evidence
-
Davidson MH (2005) Clinical significance of statin pleiotropic effects hypotheses versus evidence. Circulation 111:2280-2281
-
(2005)
Circulation
, vol.111
, pp. 2280-2281
-
-
Davidson, M.H.1
-
23
-
-
84863613858
-
Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2
-
PignatelliP Carnevale R, Pastori D et al (2012) Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2. Circulation 126:92-103
-
(2012)
Circulation
, vol.126
, pp. 92-103
-
-
Pignatelli, P.1
Carnevale, R.2
Pastori, D.3
-
24
-
-
33847404392
-
Treatment With Ezetimibe Plus Low-Dose Atorvastatin Compared With Higher-Dose Atorvastatin Alone. Is Sufficient Cholesterol-Lowering Enough to Inhibit Platelets?
-
DOI 10.1016/j.jacc.2006.10.064, PII S0735109706031135
-
Piorkowski M, Fischer S, Stellbaum C et al (2007) Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets? J Am Coll Cardiol 49:1035-1042 (Pubitemid 46349499)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.10
, pp. 1035-1042
-
-
Piorkowski, M.1
Fischer, S.2
Stellbaum, C.3
Jaster, M.4
Martus, P.5
Morguet, A.J.6
Schultheiss, H.-P.7
Rauch, U.8
-
25
-
-
84877728751
-
Impact of high dose atorvastatin on the pharmacodynamic effects of double dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study
-
Leoncini M, Toso A, Maioli M et al (2013) Impact of high dose atorvastatin on the pharmacodynamic effects of double dose clopidogrel in patients undergoing percutaneous coronary interventions: the ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study. JACC Cardiovasc Interv 6(2):169-179
-
(2013)
JACC Cardiovasc Interv
, vol.6
, Issue.2
, pp. 169-179
-
-
Leoncini, M.1
Toso, A.2
Maioli, M.3
-
26
-
-
77953911457
-
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate
-
Bonello L, Tantry US, Marcucci R et al (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919-933
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 919-933
-
-
Bonello, L.1
Tantry, U.S.2
Marcucci, R.3
-
27
-
-
84862992613
-
Pharmacogenetics of clopidogrel: Comparison between a standard and a rapid genetic testing
-
Saracini C, Vestrini A, Galora S et al (2012) Pharmacogenetics of clopidogrel: comparison between a standard and a rapid genetic testing. Genet Test Mol Biomarkers 16:500-503
-
(2012)
Genet Test Mol Biomarkers
, vol.16
, pp. 500-503
-
-
Saracini, C.1
Vestrini, A.2
Galora, S.3
-
28
-
-
62949165644
-
Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study
-
Han Y, Li Y, Wang S et al (2009) Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study. Am Heart J 157:733-739
-
(2009)
Am Heart J
, vol.157
, pp. 733-739
-
-
Han, Y.1
Li, Y.2
Wang, S.3
-
29
-
-
77958571929
-
Pilot Study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity
-
Barker CM, Murray SS, Teirstein PS et al (2010) Pilot Study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity. J Am Coll Cardiol Intv 3:1001-1007
-
(2010)
J Am Coll Cardiol Intv
, vol.3
, pp. 1001-1007
-
-
Barker, C.M.1
Murray, S.S.2
Teirstein, P.S.3
-
30
-
-
79851480679
-
High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial and inflammation: Results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study
-
Patti G, Greco D, Dicuonzo G et al (2011) High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial and inflammation: results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study. J Am Coll Cardiol 57:771-778
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 771-778
-
-
Patti, G.1
Greco, D.2
Dicuonzo, G.3
-
31
-
-
84861230787
-
The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (The EFFICIENT Trial)
-
Ari H, Ozkan H, Karacinar A et al (2012) The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (The EFFICIENT Trial). Int J Cardiol 157:374-380
-
(2012)
Int J Cardiol
, vol.157
, pp. 374-380
-
-
Ari, H.1
Ozkan, H.2
Karacinar, A.3
-
32
-
-
79952598836
-
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: The GRAVITAS randomized trial
-
Investigators GRAVITAS
-
Price MJ, Berger PB, Teirstein PS, Investigators GRAVITAS et al (2011) Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 305:1097-1105
-
(2011)
JAMA
, vol.305
, pp. 1097-1105
-
-
Price, M.J.1
Berger, P.B.2
Teirstein, P.S.3
-
33
-
-
84870032410
-
Bedside monitoring to adjust antiplatelet therapy for coronary stenting
-
Investigators ARCTIC
-
Collet JP, Cuisset T, Rangé G, Investigators ARCTIC et al (2012) Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 367:2100-2109
-
(2012)
N Engl J Med
, vol.367
, pp. 2100-2109
-
-
Collet, J.P.1
Cuisset, T.2
Rangé, G.3
-
34
-
-
38049033935
-
Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: A meta-analysis
-
Cholesterol Treatment Trialists' (CTT) Collaborators
-
Cholesterol Treatment Trialists' (CTT) Collaborators (2008) Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371:117-125
-
(2008)
Lancet
, vol.371
, pp. 117-125
-
-
-
35
-
-
77955989559
-
Profiling induction of cytochrome P450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes
-
Feidt DM, Klein Kathrin et al (2010) Profiling induction of cytochrome P450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes. Drug Metab Dispos 38:1589-1597
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 1589-1597
-
-
Feidt, D.M.1
Klein, K.2
-
36
-
-
77950555307
-
Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: The OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study
-
Gajos G, Rostoff P, Undas A et al (2010) Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study. J Am Coll Cardiol 55:1671-1678
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1671-1678
-
-
Gajos, G.1
Rostoff, P.2
Undas, A.3
|